Both in Pharmaceuticals
Rapport Therapeutics vs Pacira BioSciences
Over the past year RAPP returned −5.6% and PCRX returned +64.0%; their daily moves had a correlation of 0.07.
RAPP −5.6% PCRX +64.0%Growth of $1, one year, split-adjusted
| Metric | RAPP | PCRX |
|---|---|---|
| Price | $25.44 | $36.39 |
| Market cap | $1.43B | $1.45B |
| Today | +1.23% | −0.03% |
| 1 month | −21.0% | +45.3% |
| 6 months | −28.5% | +46.8% |
| Year to date | −16.2% | +40.6% |
| 1 year | −12.1% | +70.2% |
| Revenue growth (YoY) | — | +6.2% |
| Gross margin | — | 77.0% |
| Net margin | — | 2.4% |
| P/E (TTM) | — | 99.2× |
| Price / sales | 71.6× | 1.9× |
| Net cash | $436.1M | -$112.1M |
| Dividend yield | — | — |
| Volatility (60d) | 79.5% | 78.5% |
| Short % of float | 10.9% | 11.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).